Clinical Trial NCT06932471

Trial

Wuhan MY008211A-PNH-3-01 (NCT06932471)

Clinical trial ID

NCT06932471

Drug name

MY008211A tablets

Company:

Wuhan Createrna Science and Technology Co., Ltd

Drug trade name

Clinicaltrials.gov

Learn more

Phase of study

3

Current status

Recruiting

Start

08/2024

Substance

Research question

To evaluate the efficacy of MY008211A in PNH patients with residual anemia despite treatment with anti-C5 antibody.

Delivery method of drug

Frequency

Clinical trial locations

China